Evidence map›Paper›PMID 34299528›Full record

ArticleMolecules (Basel, Switzerland)2021

Synthesis, Antibacterial and Antifungal Activity of New 3-Aryl-5

Sergii Demchenko, Roman Lesyk, Oleh Yadlovskyi, Johannes Zuegg, Alysha G Elliott, Iryna Drapak, Yuliia Fedchenkova, Zinaida Suvorova, Anatolii Demchenko

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Frontiers in pharmacology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Di-, tetra-, and perhydropyrrolo[1,2-Chemistry of heterocyclic compounds · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sergii DemchenkoInstitute of Pharmacology and Toxicology, Antona Tsedika 14, 03057 Kyiv, Ukraine.
Roman LesykDepartment of Public Health, Dietetics and Lifestyle Disorders, Faculty of Medicine, University of Information Technology and Management in Rzeszow, 35-225 Rzeszow, Poland.ORCID 0000-0002-3322-0080
Oleh YadlovskyiInstitute of Pharmacology and Toxicology, Antona Tsedika 14, 03057 Kyiv, Ukraine.
Johannes ZueggThe Community for Open Antimicrobial Drug Discovery (CO-ADD), Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, Brisbane 4072, Australia.
Alysha G ElliottThe Community for Open Antimicrobial Drug Discovery (CO-ADD), Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, Brisbane 4072, Australia.ORCID 0000-0002-2983-0484
Iryna DrapakDepartment of General, Inorganic, Physical and Colloidal Chemistry, Danylo Halytsky Lviv National Medical University, Pekarska 69, 79010 Lviv, Ukraine.ORCID 0000-0002-6830-2908
Yuliia FedchenkovaDepartment of Chemistry and Pharmacy, Nizhyn Mykola Gogol State University, 16600 Nizhyn, Ukraine.
Zinaida SuvorovaInstitute of Pharmacology and Toxicology, Antona Tsedika 14, 03057 Kyiv, Ukraine.ORCID 0000-0001-6307-0741
Anatolii DemchenkoInstitute of Pharmacology and Toxicology, Antona Tsedika 14, 03057 Kyiv, Ukraine.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of novel 3-aryl-5

Indexed as

Anti-Bacterial AgentsAntifungal AgentsBacteriaBacterial InfectionsFungiHEK293 CellsHumansImidazolesMicrobial Sensitivity TestsMycosesSaltsStructure-Activity RelationshipAnti-Bacterial AgentsAntifungal AgentsImidazolesSalts5H-imidazo[1,2-a]azepines5H-pyrrolo[1,2-a]imidazolesantibacterial activityantifungal activityin vitro testsminimum inhibitory concentrationquaternary salts

Identifiers

PMID34299528
PMCPMC8305969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.